Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions NCT03937791 Squamous Lntrae...
Neoplasms, Squa...
Vulvar HSIL
E7 T Cell Recep...
18 Years - National Institutes of Health Clinical Center (CC) View A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 NCT04908111 Non-small Cell ...
Esophageal Neop...
ChAdOx1-MAGEA3-...
MVA-MAGEA3
Standard of car...
MVA-NYESO
18 Years - Cancer Research UK View Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients NCT02526953 Anus Neoplasms
Carcinoma, Squa...
Anus Diseases
Neoplasms
Neoplasms, Squa...
Carcinoma
Paclitaxel
Capecitabine
Capecitabine
Mitomycins
Mitomycins
Radiotherapy
18 Years - 70 Years Blokhin's Russian Cancer Research Center View Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea NCT01075828 Head and Neck C...
Cetuximab
- Merck KGaA, Darmstadt, Germany View Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer NCT00272181 Squamous Cell C...
Carcinoma, Squa...
Neoplasms, Squa...
Head and Neck N...
Mouth Neoplasms
Head and Neck C...
Proxinium
18 Years - Sesen Bio, Inc. View PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors NCT03685591 Breast Neoplasm...
Prostate Neopla...
Neoplasms, Squa...
Melanoma
Mesothelioma
Pancreatic Neop...
Colorectal Neop...
Carcinoma, Rena...
Liver Neoplasms
PF-06952229
Enzalutamide
18 Years - Pfizer View A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck NCT01075841 Neoplasms, Squa...
Cetuximab
- Merck KGaA, Darmstadt, Germany View An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck NCT01142869 Carcinoma, Squa...
Cetuximab
- Merck KGaA, Darmstadt, Germany View Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients NCT05252078 Esophageal Squa...
Esophageal Neop...
Esophageal Dise...
Gastrointestina...
Gastrointestina...
Digestive Syste...
Digestive Syste...
Neoplasms by Si...
Neoplasms by Hi...
Neoplasms, Squa...
Carcinoma, Squa...
Anlotinib hydro...
TQB2450
18 Years - Jiangxi Provincial Cancer Hospital View Safety Study of SEA-CD40 in Cancer Patients NCT02376699 Carcinoma, Non-...
Carcinoma, Squa...
Hodgkin Disease
Lymphoma
Lymphoma, B-Cel...
Lymphoma, Folli...
Lymphoma, Large...
Melanoma
Neoplasm Metast...
Neoplasms, Head...
Neoplasms, Squa...
Non-Small Cell ...
Non-Small Cell ...
Non-small Cell ...
Squamous Cell C...
Squamous Cell C...
Squamous Cell C...
Squamous Cell N...
Lymphoma, Non-H...
Pancreatic Aden...
Intravenous (IV...
Pembrolizumab
Subcutaneous (S...
Gemcitabine
Nab-paclitaxel
18 Years - Seagen Inc. View Safety Study of SEA-CD40 in Cancer Patients NCT02376699 Carcinoma, Non-...
Carcinoma, Squa...
Hodgkin Disease
Lymphoma
Lymphoma, B-Cel...
Lymphoma, Folli...
Lymphoma, Large...
Melanoma
Neoplasm Metast...
Neoplasms, Head...
Neoplasms, Squa...
Non-Small Cell ...
Non-Small Cell ...
Non-small Cell ...
Squamous Cell C...
Squamous Cell C...
Squamous Cell C...
Squamous Cell N...
Lymphoma, Non-H...
Pancreatic Aden...
Intravenous (IV...
Pembrolizumab
Subcutaneous (S...
Gemcitabine
Nab-paclitaxel
18 Years - Seagen Inc. View Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma NCT03817567 Esophageal Squa...
recombinant ant...
18 Years - 75 Years Sinocelltech Ltd. View Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma NCT04124198 Oropharynx Canc...
Oropharynx Squa...
Carcinoma, Squa...
Carcinoma
Oropharyngeal N...
Neoplasms, Squa...
Neoplasms, Glan...
Neoplasms by Hi...
Pharyngeal Neop...
Otorhinolaryngo...
Head and Neck N...
Neoplasms by Si...
Otorhinolaryngo...
Pharyngeal Dise...
Papillomavirus ...
Virus Diseases
DNA Virus Infec...
Tumor Virus Inf...
Quality of Life
Intensity-Modul...
Cisplatin
Nimorazole.
Transoral Robot...
18 Years - Rigshospitalet, Denmark View Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma NCT04124198 Oropharynx Canc...
Oropharynx Squa...
Carcinoma, Squa...
Carcinoma
Oropharyngeal N...
Neoplasms, Squa...
Neoplasms, Glan...
Neoplasms by Hi...
Pharyngeal Neop...
Otorhinolaryngo...
Head and Neck N...
Neoplasms by Si...
Otorhinolaryngo...
Pharyngeal Dise...
Papillomavirus ...
Virus Diseases
DNA Virus Infec...
Tumor Virus Inf...
Quality of Life
Intensity-Modul...
Cisplatin
Nimorazole.
Transoral Robot...
18 Years - Rigshospitalet, Denmark View Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma NCT03817567 Esophageal Squa...
recombinant ant...
18 Years - 75 Years Sinocelltech Ltd. View Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer NCT00272181 Squamous Cell C...
Carcinoma, Squa...
Neoplasms, Squa...
Head and Neck N...
Mouth Neoplasms
Head and Neck C...
Proxinium
18 Years - Sesen Bio, Inc. View Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma NCT03817567 Esophageal Squa...
recombinant ant...
18 Years - 75 Years Sinocelltech Ltd. View CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial NCT00847912 Carcinoma, Basa...
Carcinoma, Squa...
Skin Neoplasms
Skin Diseases
Neoplasms, Basa...
Neoplasms, Squa...
Carcinoma
5-fluorouracil
Placebo, vehicl...
- VA Office of Research and Development View